Bio Protocol is projected to rise to $0.0498 by 2027, a +70% move from its current price of $0.0284. BIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 26/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.0268 | $0.0284 | $0.03 | -0.32% |
| Jul 13 | $0.0261 | $0.0283 | $0.0306 | -0.65% |
| Jul 14 | $0.0255 | $0.0282 | $0.0311 | -0.97% |
| Jul 15 | $0.0251 | $0.0281 | $0.0315 | -1.29% |
| Jul 16 | $0.0246 | $0.028 | $0.0318 | -1.61% |
| Jul 17 | $0.0243 | $0.0279 | $0.0321 | -1.92% |
| Jul 18 | $0.0239 | $0.0278 | $0.0323 | -2.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0239 | $0.0278 | $0.0323 | -2.24% |
| Week 2 | $0.022 | $0.0272 | $0.0336 | -4.43% |
| Week 3 | $0.0205 | $0.0266 | $0.0345 | -6.57% |
| Week 4 | $0.0192 | $0.026 | $0.0351 | -8.67% |
| Week 5 | $0.0181 | $0.0254 | $0.0356 | -10.71% |
| Week 6 | $0.0172 | $0.0248 | $0.0359 | -12.71% |
| Week 7 | $0.0163 | $0.0243 | $0.0362 | -14.67% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BIO is a curation and liquidity protocol for Decentralized Science (DeSci). It aims to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).
The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.
The BIO team helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science, as BIO seeks to broaden participation in tokenized biotech initiatives.
BIO (Bio Protocol) is currently trading at $0.0298 and sits with a market cap of $63.82M, ranked 379. The asset has an all-time high of $0.889 and an all-time low of $0.0159. The price action is currently near the balance of near-term moving averages, with the SMA50 at $0.0375 and the SMA200 at $0.0356, and the 30-day price range extending from $0.0195 to $0.0402.
Forecasts outline a path of variable returns across years, with an average price rising from $0.028 in 2026 to $0.1111 by 2050, a max of $0.2556 and a demonstrated ROI up to 297.1% in 2050. The outlook reflects a mix of Neutral and Bullish sentiment across years, signaling upside potential but also the inherent uncertainty of crypto markets.
A major floor 42.7% below — a decisive break under it would weaken the trend.
The nearest floor, 9.1% below — buyers have tended to step in here.
The nearest ceiling, 28.3% above — a clean break opens room to run.
A major ceiling 113.8% above — clearing it would confirm fresh momentum.
Key BIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0287 | Sell | $0.0289 | Sell |
| MA 10 | $0.0293 | Sell | $0.0295 | Sell |
| MA 20 | $0.031 | Sell | $0.0304 | Sell |
| MA 50 | $0.0327 | Sell | $0.0319 | Sell |
| MA 100 | $0.0312 | Sell | $0.0328 | Sell |
| MA 200 | $0.0328 | Sell | $0.0398 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.18 | Neutral |
| Stoch RSI (14) | 21.73 | Neutral |
| CCI (20) | -65.20 | Neutral |
| Williams %R (14) | -86.30 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -19.95 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 13.70 | Buy |
| TRIX (15) | -0.40 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 44.25 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 0.03 | Buy |
| ADX (14) | 12.14 | Neutral |
| ATR (14) | 0.00 | Info |
The near-term technical picture is Neutral, with RSI(14) around 40. The asset trades around key moving averages, with SMA50 at $0.0375 and SMA200 at $0.0356, indicating price action hovering near medium-term trend lines.
Support sits at $0.0265 and resistance at $0.0578, framing the immediate trading range around the current price. The 30-day range spans from $0.0195 to $0.0402, highlighting ongoing volatility within a relatively tight band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0161 | $0.0292 | $0.0292 | 0% | Neutral | |
| $0.0361 | $0.0498 | $0.0744 | +70% | Bullish | |
| $0.0332 | $0.0488 | $0.0777 | +67% | Bullish | |
| $0.024 | $0.0372 | $0.0621 | +27% | Bullish | |
| $0.0309 | $0.0502 | $0.0872 | +72% | Bullish | |
| $0.049 | $0.0831 | $0.1496 | +184% | Bullish | |
| $0.0434 | $0.0768 | $0.1425 | +163% | Bullish | |
| $0.0299 | $0.0551 | $0.1051 | +88% | Bullish | |
| $0.0469 | $0.0899 | $0.1758 | +207% | Bullish | |
| $0.0712 | $0.1418 | $0.2838 | +385% | Bullish | |
| $0.043 | $0.0956 | $0.2103 | +227% | Bullish | |
| $0.1122 | $0.2493 | $0.5734 | +752% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.0161 | $0.0292 | $0.0306 | +2.81% |
| August 2026 | $0.0159 | $0.0194 | $0.0246 | -33.78% |
| September 2026 | $0.0172 | $0.0212 | $0.0275 | +9.33% |
| October 2026 | $0.0181 | $0.0226 | $0.0298 | +6.88% |
| November 2026 | $0.0146 | $0.0184 | $0.0247 | -18.48% |
| December 2026 | $0.0137 | $0.0175 | $0.0236 | -5.40% |
Click any year to see its month-by-month BIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BIO price prediction for 2026 points to an average of $0.0292 (low $0.0161, high $0.0292) — a potential gain of 0% on today's $0.0284. A consolidation phase looks the most probable path here.
In 2027, BIO is projected to trade between $0.0361 and $0.0744, averaging $0.0498 — a potential gain of +70% from today's $0.0284. That is up +70% on the projected 2026 average. Momentum favours further upside here.
Bio Protocol's 2028 outlook centres on $0.0488, within a $0.0332 to $0.0777 range. That is -2% versus the projected 2027 average. That marks a +67% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BIO could reach as high as $0.0621, with a base case around $0.0372 and support toward $0.024 — roughly +27% from $0.0284. Momentum favours further upside here.
Expect BIO to range from $0.0309 to $0.0872 through 2030. The $0.0502 average target implies a +72% move from current prices. That is up +35% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The BIO price prediction for 2031 points to an average of $0.0831 (low $0.049, high $0.1496) — a potential gain of +184% on today's $0.0284. Momentum favours further upside here.
In 2032, BIO is projected to trade between $0.0434 and $0.1425, averaging $0.0768 — a potential gain of +163% from today's $0.0284. That is -8% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Bio Protocol's 2033 outlook centres on $0.0551, within a $0.0299 to $0.1051 range. That is -28% versus the projected 2032 average. That marks a +88% change versus current levels. Momentum favours further upside here.
By 2034, BIO could reach as high as $0.1758, with a base case around $0.0899 and support toward $0.0469 — roughly +207% from $0.0284. Buyers look set to stay in control over this stretch.
Expect BIO to range from $0.0712 to $0.2838 through 2035. The $0.1418 average target implies a +385% move from current prices. That is up +58% on the projected 2034 average. Momentum favours further upside here.
The BIO price prediction for 2040 points to an average of $0.0956 (low $0.043, high $0.2103) — a potential gain of +227% on today's $0.0284. Buyers look set to stay in control over this stretch.
In 2050, BIO is projected to trade between $0.1122 and $0.5734, averaging $0.2493 — a potential gain of +752% from today's $0.0284. That is up +161% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BIO today (≈ 35,157.51622 BIO) could be worth
$8,764.3
+$7,764.3 (+776%) by 2050 · US Dollar
Based on the average projected BIO price of $0.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIOwould be worth at today's price.
$1,000 invested in BIO on Jul 1, 2025 (≈ 19,259.159058 BIO) would be worth
$547.8
-$452.2 (-45.2%) today · 0.55× · US Dollar
Based on a BIO entry price of $0.051923 vs. today's $0.028443.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.030091 | $945.25 | -5.5% |
| 1 month ago | $0.030654 | $927.88 | -7.2% |
| 3 months ago | $0.016734 | $1,699.77 | +70.0% |
| 6 months ago | $0.045896 | $619.74 | -38.0% |
| 1 year ago | $0.051923 | $547.8 | -45.2% |
| All time (1.1y) ago | $0.087759 | $324.11 | -67.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIO forecast.
Our base-case forecast reaches $0.057 around 2031.
Implied market cap at $0.057: $122.27M
The multi-year forecast shows a mixture of years with upside potential and others with more modest gains. In 2026 the min is $0.0161, the avg is $0.028 and the max is $0.028, with ROI of 0% and NEUTRAL sentiment.
In 2027 the min is $0.0232, avg $0.0322 and max $0.0484, with ROI 15.1% and NEUTRAL sentiment; in 2028 the min is $0.0233, avg $0.0344 and max $0.0549, ROI 22.9% and sentiment BULLISH. By 2031 the forecast shows ROI of 54.7% (avg $0.0433) and by 2032 ROI of 72.9% (avg $0.0484), both with BULLISH sentiment.
The trajectory continues with notable gains in 2035 (avg $0.0748, ROI 167.3%, BULLISH) and 2050 (avg $0.1111, max $0.2556, ROI 297.1%, BULLISH). The longer horizon includes periods of higher volatility, underscoring that these are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030, the min is $0.018, the avg is $0.0292 and the max is $0.0509. The ROI is 4.4% and the sentiment is NEUTRAL.
The forecast shows a mix of outcomes, with higher ROIs in years like 2031 (54.7%), 2032 (72.9%), and 2050 (297.1%), alongside years with more modest or zero ROI (e.g., 2026 with 0% ROI and 2030 with 4.4%). Sentiment varies between NEUTRAL and BULLISH across years.
The forecast maximum by 2050 is $0.2556, and the 2050 average is $0.1111, so reaching $0.10 lies within the projected path though not guaranteed.
Yes. The 2028 forecast shows an average of $0.0344 and a max of $0.0549, both above the current price of $0.0298.
All-time high: $0.889. All-time low: $0.0159.
Bio Protocol Community Discussion
0Share your Bio Protocol price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.